Outcome of Stage T2 or Greater Renal Cell Cancer Treated With Partial Nephrectomy

Rodney H. Breau, Paul L. Crispen, Rafael E Jimenez, Christine M. Lohse, Michael L. Blute, Bradley C. Leibovich

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

Purpose: Partial nephrectomy for stage T1 renal cell carcinoma is oncologically efficacious and safe, and may have survival advantages. We describe our experience with partial nephrectomy for T2 or greater renal cell cancer. Materials and Methods: Between 1970 and 2008 approximately 2,300 partial nephrectomies were done at our institution, including 69 for sporadic unilateral advanced stage tumors (pT2 in 32, pT3a in 28 and pT3b in 9). We reviewed outcomes in these patients compared to those in 207 treated with radical nephrectomy matched 3:1 for stage, tumor size, baseline renal function, age and gender. Results: The risk of cancer specific (HR 0.80, 95% CI 0.43-1.50, p = 0.489) and overall (HR 1.11, 95% CI 0.72-1.71, p = 0.642) death was similar for partial nephrectomy. At a median of 3.2 years of followup 15 patients (22%) with partial nephrectomy had metastatic disease vs 69 (33%) with radical nephrectomy (HR 0.74, 95% CI 0.42-1.29, p = 0.29). Four patients (6%) with partial nephrectomy had isolated local recurrence vs 7 (3%) with radical nephrectomy (HR 2.11, 95% CI 0.62-7.22, p = 0.234). In the partial nephrectomy group 12 (17%) and 2 cases (3%) were complicated by urine leak and retroperitoneal bleeding requiring intervention, respectively. The median serum creatinine increase was 9.5% (IQR 0-22) vs 33% (IQR 20-47) for partial vs radical nephrectomy (p <0.001). Conclusions: Partial nephrectomy for T2 or greater renal cell carcinoma preserves renal function and appears to achieve oncological outcomes similar to those of radical nephrectomy. The role of partial nephrectomy in patients with T2-3 tumors and a normal contralateral kidney deserves further consideration and study.

Original languageEnglish (US)
Pages (from-to)903-908
Number of pages6
JournalJournal of Urology
Volume183
Issue number3
DOIs
StatePublished - Mar 2010

Fingerprint

Nephrectomy
Renal Cell Carcinoma
Kidney
Neoplasms
Creatinine
Urine

Keywords

  • carcinoma
  • kidney
  • morbidity
  • nephrectomy
  • outcome and process assessment (health care)
  • renal cell

ASJC Scopus subject areas

  • Urology

Cite this

Breau, R. H., Crispen, P. L., Jimenez, R. E., Lohse, C. M., Blute, M. L., & Leibovich, B. C. (2010). Outcome of Stage T2 or Greater Renal Cell Cancer Treated With Partial Nephrectomy. Journal of Urology, 183(3), 903-908. https://doi.org/10.1016/j.juro.2009.11.037

Outcome of Stage T2 or Greater Renal Cell Cancer Treated With Partial Nephrectomy. / Breau, Rodney H.; Crispen, Paul L.; Jimenez, Rafael E; Lohse, Christine M.; Blute, Michael L.; Leibovich, Bradley C.

In: Journal of Urology, Vol. 183, No. 3, 03.2010, p. 903-908.

Research output: Contribution to journalArticle

Breau, RH, Crispen, PL, Jimenez, RE, Lohse, CM, Blute, ML & Leibovich, BC 2010, 'Outcome of Stage T2 or Greater Renal Cell Cancer Treated With Partial Nephrectomy', Journal of Urology, vol. 183, no. 3, pp. 903-908. https://doi.org/10.1016/j.juro.2009.11.037
Breau, Rodney H. ; Crispen, Paul L. ; Jimenez, Rafael E ; Lohse, Christine M. ; Blute, Michael L. ; Leibovich, Bradley C. / Outcome of Stage T2 or Greater Renal Cell Cancer Treated With Partial Nephrectomy. In: Journal of Urology. 2010 ; Vol. 183, No. 3. pp. 903-908.
@article{49cd0655e6f54f95b2d08bf76096245f,
title = "Outcome of Stage T2 or Greater Renal Cell Cancer Treated With Partial Nephrectomy",
abstract = "Purpose: Partial nephrectomy for stage T1 renal cell carcinoma is oncologically efficacious and safe, and may have survival advantages. We describe our experience with partial nephrectomy for T2 or greater renal cell cancer. Materials and Methods: Between 1970 and 2008 approximately 2,300 partial nephrectomies were done at our institution, including 69 for sporadic unilateral advanced stage tumors (pT2 in 32, pT3a in 28 and pT3b in 9). We reviewed outcomes in these patients compared to those in 207 treated with radical nephrectomy matched 3:1 for stage, tumor size, baseline renal function, age and gender. Results: The risk of cancer specific (HR 0.80, 95{\%} CI 0.43-1.50, p = 0.489) and overall (HR 1.11, 95{\%} CI 0.72-1.71, p = 0.642) death was similar for partial nephrectomy. At a median of 3.2 years of followup 15 patients (22{\%}) with partial nephrectomy had metastatic disease vs 69 (33{\%}) with radical nephrectomy (HR 0.74, 95{\%} CI 0.42-1.29, p = 0.29). Four patients (6{\%}) with partial nephrectomy had isolated local recurrence vs 7 (3{\%}) with radical nephrectomy (HR 2.11, 95{\%} CI 0.62-7.22, p = 0.234). In the partial nephrectomy group 12 (17{\%}) and 2 cases (3{\%}) were complicated by urine leak and retroperitoneal bleeding requiring intervention, respectively. The median serum creatinine increase was 9.5{\%} (IQR 0-22) vs 33{\%} (IQR 20-47) for partial vs radical nephrectomy (p <0.001). Conclusions: Partial nephrectomy for T2 or greater renal cell carcinoma preserves renal function and appears to achieve oncological outcomes similar to those of radical nephrectomy. The role of partial nephrectomy in patients with T2-3 tumors and a normal contralateral kidney deserves further consideration and study.",
keywords = "carcinoma, kidney, morbidity, nephrectomy, outcome and process assessment (health care), renal cell",
author = "Breau, {Rodney H.} and Crispen, {Paul L.} and Jimenez, {Rafael E} and Lohse, {Christine M.} and Blute, {Michael L.} and Leibovich, {Bradley C.}",
year = "2010",
month = "3",
doi = "10.1016/j.juro.2009.11.037",
language = "English (US)",
volume = "183",
pages = "903--908",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Outcome of Stage T2 or Greater Renal Cell Cancer Treated With Partial Nephrectomy

AU - Breau, Rodney H.

AU - Crispen, Paul L.

AU - Jimenez, Rafael E

AU - Lohse, Christine M.

AU - Blute, Michael L.

AU - Leibovich, Bradley C.

PY - 2010/3

Y1 - 2010/3

N2 - Purpose: Partial nephrectomy for stage T1 renal cell carcinoma is oncologically efficacious and safe, and may have survival advantages. We describe our experience with partial nephrectomy for T2 or greater renal cell cancer. Materials and Methods: Between 1970 and 2008 approximately 2,300 partial nephrectomies were done at our institution, including 69 for sporadic unilateral advanced stage tumors (pT2 in 32, pT3a in 28 and pT3b in 9). We reviewed outcomes in these patients compared to those in 207 treated with radical nephrectomy matched 3:1 for stage, tumor size, baseline renal function, age and gender. Results: The risk of cancer specific (HR 0.80, 95% CI 0.43-1.50, p = 0.489) and overall (HR 1.11, 95% CI 0.72-1.71, p = 0.642) death was similar for partial nephrectomy. At a median of 3.2 years of followup 15 patients (22%) with partial nephrectomy had metastatic disease vs 69 (33%) with radical nephrectomy (HR 0.74, 95% CI 0.42-1.29, p = 0.29). Four patients (6%) with partial nephrectomy had isolated local recurrence vs 7 (3%) with radical nephrectomy (HR 2.11, 95% CI 0.62-7.22, p = 0.234). In the partial nephrectomy group 12 (17%) and 2 cases (3%) were complicated by urine leak and retroperitoneal bleeding requiring intervention, respectively. The median serum creatinine increase was 9.5% (IQR 0-22) vs 33% (IQR 20-47) for partial vs radical nephrectomy (p <0.001). Conclusions: Partial nephrectomy for T2 or greater renal cell carcinoma preserves renal function and appears to achieve oncological outcomes similar to those of radical nephrectomy. The role of partial nephrectomy in patients with T2-3 tumors and a normal contralateral kidney deserves further consideration and study.

AB - Purpose: Partial nephrectomy for stage T1 renal cell carcinoma is oncologically efficacious and safe, and may have survival advantages. We describe our experience with partial nephrectomy for T2 or greater renal cell cancer. Materials and Methods: Between 1970 and 2008 approximately 2,300 partial nephrectomies were done at our institution, including 69 for sporadic unilateral advanced stage tumors (pT2 in 32, pT3a in 28 and pT3b in 9). We reviewed outcomes in these patients compared to those in 207 treated with radical nephrectomy matched 3:1 for stage, tumor size, baseline renal function, age and gender. Results: The risk of cancer specific (HR 0.80, 95% CI 0.43-1.50, p = 0.489) and overall (HR 1.11, 95% CI 0.72-1.71, p = 0.642) death was similar for partial nephrectomy. At a median of 3.2 years of followup 15 patients (22%) with partial nephrectomy had metastatic disease vs 69 (33%) with radical nephrectomy (HR 0.74, 95% CI 0.42-1.29, p = 0.29). Four patients (6%) with partial nephrectomy had isolated local recurrence vs 7 (3%) with radical nephrectomy (HR 2.11, 95% CI 0.62-7.22, p = 0.234). In the partial nephrectomy group 12 (17%) and 2 cases (3%) were complicated by urine leak and retroperitoneal bleeding requiring intervention, respectively. The median serum creatinine increase was 9.5% (IQR 0-22) vs 33% (IQR 20-47) for partial vs radical nephrectomy (p <0.001). Conclusions: Partial nephrectomy for T2 or greater renal cell carcinoma preserves renal function and appears to achieve oncological outcomes similar to those of radical nephrectomy. The role of partial nephrectomy in patients with T2-3 tumors and a normal contralateral kidney deserves further consideration and study.

KW - carcinoma

KW - kidney

KW - morbidity

KW - nephrectomy

KW - outcome and process assessment (health care)

KW - renal cell

UR - http://www.scopus.com/inward/record.url?scp=75849129104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75849129104&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2009.11.037

DO - 10.1016/j.juro.2009.11.037

M3 - Article

C2 - 20083271

AN - SCOPUS:75849129104

VL - 183

SP - 903

EP - 908

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3

ER -